07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Dasatinib Tablets 50 Mg

Name: Dasatinib Tablets 50 Mg
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 9185 INR
Availability: InStock

Price 9185 INR/ Pack

Get a Price/Quote

MOQ : 1 Pack

Dasatinib Tablets 50 Mg Specification

Brand Name
Beedan

Origin of Medicine
India

Packaging Type
Box

Indication
Philadelphia chromosome positive chronic myeloid leukemia

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
60 Tablets

Life Span
Check expiry date on pack

Salt Composition
Dasatinib

Drug Type
Allopathic

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anticancer medication

Recommended For
Adults and children with Philadelphia chromosome positive CML

Dosage
50 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults and children

Quantity
60 Tablets

Storage Instructions
Store below 30C, protect from moisture

Therapeutic Class
Oncology

Prescription Required
Yes

Administration Route
Oral

Color
White

Child Resistant Cap
Yes

Tablet Strength
50 mg

Dasatinib Tablets 50 Mg Trade Information

Minimum Order Quantity
1 Pack

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Domestic Market
All India

Dasatinib Tablets 50 Mg About

Dasatinib Tablets 50 mg, branded as Beedan, are a hot-selling anticancer solution originating from India and highly regarded for their optimum efficacy in treating adults and children with Philadelphia chromosome positive chronic myeloid leukemia (CML). These customizable, flawless tablets ensure the best outcomes when administered as directed by a physician. Utilise this offer of 60 white, child-resistant tablets per box for reliable and secure handling. Dasatinib Tablets guarantee the best results with allopathic, prescription-only strength, supported by rigorous Indian pharmaceutical standards, for absolute peace of mind in oncology care.

Key Features and Usage of Dasatinib Tablets 50 Mg

Dasatinib Tablets 50 mg are specifically utilized by adults and children suffering from Philadelphia chromosome positive chronic myeloid leukemia. This best-in-class oncology medication provides an optimum therapeutic effect as part of a prescribed treatment regimen. Its features include an easy oral administration route, child-resistant cap, and a flawless white tablet form. Designed for both children and adults, this medication stands out for its reliability and precise dosage, fostering successful cancer care outcomes.

Sample, Market Coverage, and Supply Details for Dasatinib Tablets 50 Mg

Available samples of Dasatinib Tablets 50 mg can be delivered upon request for quality inspection. With a main domestic market coverage across India, shipment is handled swiftly by experienced exporters and suppliers. The product, packaged in boxes of 60 tablets, is always ready for dispatch at a competitive list price and with robust supply ability. Clients benefit from seamless logistics, ensuring flawless product handling from order confirmation to safe delivery.

FAQ's of Dasatinib Tablets 50 Mg:

Q: How should Dasatinib Tablets 50 mg be taken for best results?

A: Dasatinib Tablets 50 mg should be taken orally at the dosage prescribed by your physician. Always follow your doctor's instructions for optimum therapeutic benefit.

Q: What is the main therapeutic indication for Dasatinib Tablets 50 mg?

A: This medication is indicated for adults and children diagnosed with Philadelphia chromosome positive chronic myeloid leukemia (CML).

Q: When should Dasatinib Tablets 50 mg be used during treatment?

A: Dasatinib Tablets are used as part of the treatment plan determined by your oncologist for Philadelphia chromosome positive CML, and should be started only after a prescription is provided.